We further confirmed the abnormal expression of FDX1, SUMF1, and SLC31A1, and found the correlation between high expression of FDX1 and SLC31A1 protein and poor prognosis in glioma patients, which provided a new direction for the future research on the treatment of glioma using the cuproptosis mechanism. This evidence concerns the gene SUMF1 and central nervous system cancer.